P2Y12 Inhibitor Adherence Patterns in Patients with Acute Coronary Syndrome

被引：0
|
作者：
Ozaki, Aya
Ko, Dennis T.
Chong, Alice
Fang, Jiming
Austin, Peter
Sud, Maneesh
Jackevicius, Cynthia A.
机构：
来源：
CIRCULATION | 2021年 / 144卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10843
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Trajectories of P2Y12 inhibitor adherence in patients with acute coronary syndromes
    Moon, Jungyeon
    Ozaki, Aya F.
    Chong, Alice
    Sud, Maneesh
    Fang, Jiming
    Austin, Peter C.
    Ko, Dennis T.
    Jackevicius, Cynthia A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [2] P2Y12 INHIBITOR ADHERENCE TRAJECTORIES IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Turgeon, Ricky D.
    Koshman, Sheri
    Dong, Yuan
    Graham, Michelle
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 16 - 16
  • [3] P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications
    Turgeon, Ricky D.
    Koshman, Sheri L.
    Dong, Yuan
    Graham, Michelle M.
    EUROPEAN HEART JOURNAL, 2022, 43 (24) : 2303 - 2313
  • [4] P2Y12 inhibitor in acute coronary syndromes
    Wiwanitkit, Viroj
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (04): : 249 - 249
  • [5] Selection of P2Y12 Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome
    Tantry, Udaya S.
    Navarese, Eliano P.
    Myat, Aung
    Gurbel, Paul A.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 460 - 470
  • [6] What Are Optimal P2Y12 Inhibitor and Schedule of Administration in Patients With Acute Coronary Syndrome?
    Cohen, Michael V.
    Downey, James M.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (02) : 121 - 130
  • [7] The impact of in-hospital P2Y12 inhibitor switch in patients with acute coronary syndrome
    Gajanana, Deepakraj
    Weintraub, William S.
    Kolm, Paul
    Rogers, Toby
    Iantorno, Micaela
    Buchanan, Kyle D.
    Ben-Dor, Itsik
    Pichard, Augusto D.
    Satler, Lowell F.
    Thourani, Vinod H.
    Torguson, Rebecca
    Okubagzi, Petros G.
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2018, 19 (08) : 912 - 916
  • [8] Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)
    Eliaz, R.
    Mengesha, B.
    Ovdat, T.
    Iakobishvili, Z.
    Hasdai, D.
    Kheifets, M.
    Klempfner, R.
    Beigel, R.
    Kalmanovich, E.
    Alcalai, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1414 - 1414
  • [9] Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina
    Bazemore, Taylor C.
    Nanna, Michael G.
    Rao, Sunil V.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 44 (03) : 303 - 315
  • [10] Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina
    Taylor C. Bazemore
    Michael G. Nanna
    Sunil V. Rao
    Journal of Thrombosis and Thrombolysis, 2017, 44 : 303 - 315
12345